Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicus Sciences Acquisition's earnings before interest and taxes (EBIT) for the
three
months ended in Sep. 2022 was $-0.17 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.70 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Medicus Sciences Acquisition's annualizedROC % for the quarter that ended in Sep. 2022 was -0.75%.
Medicus Sciences Acquisition's annualizedROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -1,242.86%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Shell Companies subindustry, Medicus Sciences Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicus Sciences Acquisition EV-to-EBIT vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Medicus Sciences Acquisition's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Sciences Acquisition (MSACW) has a EBIT of $-0.70 Mil as of Sep. 2022. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medicus Sciences Acquisition.
Is Medicus Sciences Acquisition's EBIT too high?
Medicus Sciences Acquisition's current EBIT is $-0.70 Mil. Overall, Medicus Sciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Sciences Acquisition's EBIT compare to GENQ and DUET?
Medicus Sciences Acquisition's EBIT of $-0.70 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Diversified Financial Services company?
A good EBIT depends on the Diversified Financial Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medicus Sciences Acquisition. Medicus Sciences Acquisition's current EBIT is $-0.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Sciences Acquisition stock overvalued right now?
Medicus Sciences Acquisition (MSACW) has a current EBIT of $-0.70 Mil. The current EBIT is $-0.70 Mil. Medicus Sciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medicus Sciences Acquisition (MSACW), the current EBIT is $-0.70 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSACW has been successfully added to your 
